ArticleJournal for immunotherapy of cancer2022

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.

Jinyang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.